The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci

Germana Lentini, Angelina Midiri, Arnaud Firon, Roberta Galbo, Giuseppe Mancuso, Carmelo Biondo, Emanuela Mazzon, Annamaria Passantino, Letizia Romeo, Patrick Trieu-Cuot, Giuseppe Teti, Concetta Beninati

Research output: Contribution to journalArticle

Abstract

Streptococcus agalactiae (Group B Streptococcus or GBS) is a frequent cause of serious disease in newborns and adults. Epidemiological evidence indicates a strong association between GBS strains belonging to the hypervirulent CC17 clonal complex and the occurrence of meningitis in neonates. We investigate here the role of PbsP, a cell wall plasminogen binding protein, in colonization of the central nervous system by CC17 GBS. Deletion of pbsP selectively impaired the ability of the CC17 strain BM110 to colonize the mouse brain after intravenous challenge, despite its unchanged capacity to persist at high levels in the blood and to invade the kidneys. Moreover, immunization with a recombinant form of PbsP considerably reduced brain infection and lethality. In vitro, pbsP deletion markedly decreased plasmin-dependent transmigration of BM110 through brain microvascular endothelial cells. Although PbsP was modestly expressed in bacteria grown under standard laboratory conditions, pbsP expression was markedly upregulated during in vivo infection or upon contact with cultured brain endothelial cells. Collectively, our studies indicate that PbsP is a highly conserved Plg binding adhesin, which is functionally important for invasion of the central nervous system by the hypervirulent CC17 GBS. Moreover, this antigen is a promising candidate for inclusion in a universal GBS vaccine.

Original languageEnglish
Pages (from-to)14322
JournalScientific Reports
Volume8
Issue number1
DOIs
Publication statusPublished - Sep 25 2018

Fingerprint

Streptococcus agalactiae
Plasminogen
Carrier Proteins
Brain
Central Nervous System
Endothelial Cells
Fibrinolysin
Infection
Streptococcus
Meningitis
Cell Wall
Immunization
Vaccines
Bacteria
Kidney
Antigens

Cite this

Lentini, G., Midiri, A., Firon, A., Galbo, R., Mancuso, G., Biondo, C., ... Beninati, C. (2018). The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci. Scientific Reports, 8(1), 14322. https://doi.org/10.1038/s41598-018-32774-8

The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci. / Lentini, Germana; Midiri, Angelina; Firon, Arnaud; Galbo, Roberta; Mancuso, Giuseppe; Biondo, Carmelo; Mazzon, Emanuela; Passantino, Annamaria; Romeo, Letizia; Trieu-Cuot, Patrick; Teti, Giuseppe; Beninati, Concetta.

In: Scientific Reports, Vol. 8, No. 1, 25.09.2018, p. 14322.

Research output: Contribution to journalArticle

Lentini, G, Midiri, A, Firon, A, Galbo, R, Mancuso, G, Biondo, C, Mazzon, E, Passantino, A, Romeo, L, Trieu-Cuot, P, Teti, G & Beninati, C 2018, 'The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci', Scientific Reports, vol. 8, no. 1, pp. 14322. https://doi.org/10.1038/s41598-018-32774-8
Lentini, Germana ; Midiri, Angelina ; Firon, Arnaud ; Galbo, Roberta ; Mancuso, Giuseppe ; Biondo, Carmelo ; Mazzon, Emanuela ; Passantino, Annamaria ; Romeo, Letizia ; Trieu-Cuot, Patrick ; Teti, Giuseppe ; Beninati, Concetta. / The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci. In: Scientific Reports. 2018 ; Vol. 8, No. 1. pp. 14322.
@article{48080f6975e345899c8f8c5258308105,
title = "The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci",
abstract = "Streptococcus agalactiae (Group B Streptococcus or GBS) is a frequent cause of serious disease in newborns and adults. Epidemiological evidence indicates a strong association between GBS strains belonging to the hypervirulent CC17 clonal complex and the occurrence of meningitis in neonates. We investigate here the role of PbsP, a cell wall plasminogen binding protein, in colonization of the central nervous system by CC17 GBS. Deletion of pbsP selectively impaired the ability of the CC17 strain BM110 to colonize the mouse brain after intravenous challenge, despite its unchanged capacity to persist at high levels in the blood and to invade the kidneys. Moreover, immunization with a recombinant form of PbsP considerably reduced brain infection and lethality. In vitro, pbsP deletion markedly decreased plasmin-dependent transmigration of BM110 through brain microvascular endothelial cells. Although PbsP was modestly expressed in bacteria grown under standard laboratory conditions, pbsP expression was markedly upregulated during in vivo infection or upon contact with cultured brain endothelial cells. Collectively, our studies indicate that PbsP is a highly conserved Plg binding adhesin, which is functionally important for invasion of the central nervous system by the hypervirulent CC17 GBS. Moreover, this antigen is a promising candidate for inclusion in a universal GBS vaccine.",
author = "Germana Lentini and Angelina Midiri and Arnaud Firon and Roberta Galbo and Giuseppe Mancuso and Carmelo Biondo and Emanuela Mazzon and Annamaria Passantino and Letizia Romeo and Patrick Trieu-Cuot and Giuseppe Teti and Concetta Beninati",
year = "2018",
month = "9",
day = "25",
doi = "10.1038/s41598-018-32774-8",
language = "English",
volume = "8",
pages = "14322",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci

AU - Lentini, Germana

AU - Midiri, Angelina

AU - Firon, Arnaud

AU - Galbo, Roberta

AU - Mancuso, Giuseppe

AU - Biondo, Carmelo

AU - Mazzon, Emanuela

AU - Passantino, Annamaria

AU - Romeo, Letizia

AU - Trieu-Cuot, Patrick

AU - Teti, Giuseppe

AU - Beninati, Concetta

PY - 2018/9/25

Y1 - 2018/9/25

N2 - Streptococcus agalactiae (Group B Streptococcus or GBS) is a frequent cause of serious disease in newborns and adults. Epidemiological evidence indicates a strong association between GBS strains belonging to the hypervirulent CC17 clonal complex and the occurrence of meningitis in neonates. We investigate here the role of PbsP, a cell wall plasminogen binding protein, in colonization of the central nervous system by CC17 GBS. Deletion of pbsP selectively impaired the ability of the CC17 strain BM110 to colonize the mouse brain after intravenous challenge, despite its unchanged capacity to persist at high levels in the blood and to invade the kidneys. Moreover, immunization with a recombinant form of PbsP considerably reduced brain infection and lethality. In vitro, pbsP deletion markedly decreased plasmin-dependent transmigration of BM110 through brain microvascular endothelial cells. Although PbsP was modestly expressed in bacteria grown under standard laboratory conditions, pbsP expression was markedly upregulated during in vivo infection or upon contact with cultured brain endothelial cells. Collectively, our studies indicate that PbsP is a highly conserved Plg binding adhesin, which is functionally important for invasion of the central nervous system by the hypervirulent CC17 GBS. Moreover, this antigen is a promising candidate for inclusion in a universal GBS vaccine.

AB - Streptococcus agalactiae (Group B Streptococcus or GBS) is a frequent cause of serious disease in newborns and adults. Epidemiological evidence indicates a strong association between GBS strains belonging to the hypervirulent CC17 clonal complex and the occurrence of meningitis in neonates. We investigate here the role of PbsP, a cell wall plasminogen binding protein, in colonization of the central nervous system by CC17 GBS. Deletion of pbsP selectively impaired the ability of the CC17 strain BM110 to colonize the mouse brain after intravenous challenge, despite its unchanged capacity to persist at high levels in the blood and to invade the kidneys. Moreover, immunization with a recombinant form of PbsP considerably reduced brain infection and lethality. In vitro, pbsP deletion markedly decreased plasmin-dependent transmigration of BM110 through brain microvascular endothelial cells. Although PbsP was modestly expressed in bacteria grown under standard laboratory conditions, pbsP expression was markedly upregulated during in vivo infection or upon contact with cultured brain endothelial cells. Collectively, our studies indicate that PbsP is a highly conserved Plg binding adhesin, which is functionally important for invasion of the central nervous system by the hypervirulent CC17 GBS. Moreover, this antigen is a promising candidate for inclusion in a universal GBS vaccine.

U2 - 10.1038/s41598-018-32774-8

DO - 10.1038/s41598-018-32774-8

M3 - Article

C2 - 30254272

VL - 8

SP - 14322

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

ER -